BOSTON SCIENTIFIC CORPORATION (BSX) FY2026 Q1 Balance Sheet

Balance Sheet

As of 2026-03-31

Swipe to see the full flow
BOSTON SCIENTIFIC CORPORATION (BSX) FY2026 Q1 Balance SheetBalance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.Current liabilities$4.57 BLiabilities(calculated)$18.25 BCurrent assets$8.68 BAssets$44.35 BNon-current liabilities$13.68 BNon-current assets$35.67 BEquity$26.10 BGross equity(calculated)$28.75 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSInventoriesTrade accounts receivable, netCash and cash equivalentsOther current assetsPrepaid income taxesGoodwillOther intangible assets, netProperty, plant and equipment, netDeferred tax assetsOther long-term assetsAccrued expensesAccounts payableOther current liabilitiesCurrent debt obligationsLong-term debtOther long-term liabilitiesDeferred tax liabilitiesAdditional paid-in capitalRetained earningsCommon stock, $0.01 par value - authorized 2,000,000,000 shares - 1,749,584,151 shares issued as of March 31, 2026 and 1,746,290,165 shares issued as of December 31, 2025Noncontrolling interestsCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilities (calculated)EquityGross equity (calculated)Treasury stock, at cost - 263,289,848 shares as of March 31, 2026 and December 31, 2025Accumulated other comprehensive income (loss), net of taxAccrued expensesAccrued expenses$2.51 BCurrent liabilitiesCurrent liabilities$4.57 BAccounts payableAccounts payable$1.14 BInventoriesInventories$3.12 BLiabilities (calculated)Liabilities(calculated)$18.25 BCurrent assetsCurrent assets$8.68 BOther current liabilitiesOther current liabilities$875.00 MTrade accounts receivable, netTrade accounts receivable, net$3.03 BCurrent debt obligationsCurrent debt obligations$41.00 MAssetsAssets$44.35 BCash and cash equivalentsCash and cash equivalents$1.45 BNon-current liabilitiesNon-current liabilities$13.68 BOther current assetsOther current assets$729.00 MLong-term debtLong-term debt$10.99 BPrepaid income taxesPrepaid income taxes$358.00 MOther long-term liabilitiesOther long-term liabilities$2.47 BNon-current assetsNon-current assets$35.67 BEquityEquity$26.10 BDeferred tax liabilitiesDeferred tax liabilities$219.00 MGoodwillGoodwill$18.54 BGross equity (calculated)Gross equity(calculated)$28.75 BAdditional paid-in capitalAdditional paid-in capital$21.58 BOther intangible assets, netOther intangible assets, net$7.06 BProperty, plant and equipment, netProperty, plant and equipment, net$4.06 BRetained earningsRetained earnings$6.91 BDeferred tax assetsDeferred tax assets$3.95 BCommon stock, $0.01 par value - authorized 2,000,000,000 shares - 1,749,584,151 shares issued as of March 31, 2026 and 1,746,290,165 shares issued as of December 31, 2025Common stock$17.00 MOther long-term assetsOther long-term assets$2.05 BNoncontrolling interestsNoncontrolling interests$240.00 MTreasury stock, at cost - 263,289,848 shares as of March 31, 2026 and December 31, 2025Treasury stock−$2.25 BAccumulated other comprehensive income (loss), net of taxAccumulated other comprehensive income (loss), net−$398.00 M
Chart details

BOSTON SCIENTIFIC CORPORATION (BSX) FY2026 Q1 Balance Sheet

Balance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.

Assets
44,351,000,000 US dollars
Current assets
8,684,000,000 US dollars
Non-current assets
35,667,000,000 US dollars
Liabilities (calculated)
18,247,000,000 US dollars
Current liabilities
4,571,000,000 US dollars
Non-current liabilities
13,676,000,000 US dollars
Equity
26,104,000,000 US dollars
Noncontrolling interest
240,000,000 US dollars. Included in consolidated equity; this amount is not added again.
Inventories
3,117,000,000 US dollars
Trade accounts receivable, net
3,027,000,000 US dollars
Cash and cash equivalents
1,453,000,000 US dollars
Other current assets
729,000,000 US dollars
Prepaid income taxes
358,000,000 US dollars
Goodwill
18,536,000,000 US dollars
Other intangible assets, net
7,060,000,000 US dollars
Property, plant and equipment, net
4,063,000,000 US dollars
Deferred tax assets
3,953,000,000 US dollars
Other long-term assets
2,054,000,000 US dollars
Accrued expenses
2,514,000,000 US dollars
Accounts payable
1,141,000,000 US dollars
Other current liabilities
875,000,000 US dollars
Current debt obligations
41,000,000 US dollars
Long-term debt
10,988,000,000 US dollars
Other long-term liabilities
2,469,000,000 US dollars
Deferred tax liabilities
219,000,000 US dollars
Additional paid-in capital
21,584,000,000 US dollars
Retained earnings
6,912,000,000 US dollars
Common stock, $0.01 par value - authorized 2,000,000,000 shares - 1,749,584,151 shares issued as of March 31, 2026 and 1,746,290,165 shares issued as of December 31, 2025
17,000,000 US dollars
Preferred stock, $0.01 par value - authorized 50,000,000 shares - 0 shares issued as of March 31, 2026 and December 31, 2025
0 US dollars
Noncontrolling interests
240,000,000 US dollars
Treasury stock, at cost - 263,289,848 shares as of March 31, 2026 and December 31, 2025
negative 2,251,000,000 US dollars
Accumulated other comprehensive income (loss), net of tax
negative 398,000,000 US dollars
Gross equity (calculated)
28,753,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
  • The filed non-current assets lines add up to $35,666.00 M and the non-current assets total is $35,667.00 M; the $1.00 M difference is within the rounding of the filed amounts.
BOSTON SCIENTIFIC CORPORATION (BSX) FY2026 Q1 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!